HOME >> MEDICINE >> NEWS
Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs

Hershey, Pa. --- Researchers show that giving the medication, methotrexate, to patients who suffer from juvenile rheumatoid arthritis or rheumatoid arthritis by injection, rather than orally, significantly improved the patients' health and at a dramatically reduced cost.

"We found that 73 percent of patients switched from the oral method to the injection because they were not satisfied with the way they were feeling. Two-thirds of those patients noticed improvement when they got the methotrexate by injection," says Barbara Ostrov, M.D., associate professor of pediatrics and medicine at Penn State's College of Medicine. "When our cost analysis was completed we found that it was 78 percent cheaper for patients to be treated with an injection."

Ostrov and her colleagues' paper titled, "Improved Tolerance and Cost-Effectiveness of Subcutaneous Versus Oral Methotrexate in Rheumatoid Arthritis (RA) and Juvenile Rheumatoid Arthritis (JRA)," was presented Nov. 9 at the American College of Rheumatology meeting in San Diego, Calif.

This study involved 52 patients, 36 with RA and 16 with JRA. Patients were on the oral medication for at least three months and then switched and started receiving the methotrexate for at least three months by injection.

Partially because of side effects, such as nausea, 31 percent chose to switch the way they receive their medication. After the change from an oral dose to an injection, only 4 percent still complained of side effects. Also, another third said they switched because of the cost of the oral medication.

Overall, the average cost per patient per week for those treated orally was $16.56. That compares to just $3.57 for those treated by injection. The cost then for treating these 52 patients for one year would be nearly $45,000 compared to less than $10,000 for the group treated by injection.

"When you would extrapolate these costs to a population of 1,000 patien
'"/>

Contact: Leilyn Perri
lperri@psghs.edu
717-531-8604
Penn State
9-Nov-1998


Page: 1 2

Related medicine news :

1. Changing chemistry helps explain estrogen threat to the heart
2. Changing trends in herbal supplement use
3. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
4. Changing the timing of cancer vaccines
5. Changing prescribing behaviour through the mail
6. Changing partner increases risk of preterm birth
7. Changing Life, Challenging Cancer conference
8. Changing approaches to treating gum disease
9. UK Researcher Develops New Delivery Systems For Treatment Of Smoking Addiction
10. An Ergonomically Redesigned Analgesia Delivery Device Proves Safer And More Efficient
11. Patent Received On Drug Delivery System

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... 2017 West Pharmaceutical Services, Inc. ... injectable drug administration, today announced that it will release ... Thursday, October 26, 2017, and will follow with a ... at 9:00 a.m. Eastern Time. To participate on the ... conference ID is 94093362. ...
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
Breaking Medicine Technology:
Cached News: